Forecast: Pharmaceutical Industry Imports in Singapore

Pharmaceutical imports in Singapore have shown a notable increase from 2013 to 2023, with the value standing at $4.18 billion USD in 2023. This upward trend is characterized by a year-on-year increase of 3.51% in 2023. Observing the past five years, the compound annual growth rate (CAGR) was 5.39%. The progression from 2016 to 2023 reveals varied growth, with significant surges in 2018 (13.77%) and 2020 (12.57%). In general, the CAGR for the last decade shows periods of substantial growth interspersed with slower increases.

Future trends to watch for:

• Continued moderate growth with a forecasted five-year CAGR of 2.41%, culminating in a value of $4.87 billion USD by 2028.
• Increasing focus on innovation and technological advancements in pharmaceuticals potentially impacting import values.
• Impact of global supply chain dynamics and regulatory changes on the pharmaceutical import market.
• Growth in demand due to an aging population and expansion of healthcare infrastructure in Singapore.